Del Mar, CA, United States of America

Stephen A R Carino

This inventor holds 1 USPTO granted patent. Top assignee: Kalypsys, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen A R Carino. Retrieved from https://idiyas.com/inventor/stephen-a-r-carino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen A R Carino

Introduction

Stephen A R Carino is an accomplished inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target histamine receptors. His work is aimed at improving treatments for various diseases, including allergic rhinitis.

Latest Patents

Stephen A R Carino holds a patent for "Heterocyclic inhibitors of histamine receptors for the treatment of disease." This invention relates to salts, hydrates, and polymorphs of bicyclic heteroaryl compounds, which may be useful as inhibitors of histamine receptors for the treatment or prevention of diseases.

Career Highlights

Carino is associated with Kalypsys, Inc., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach has led to the creation of valuable therapeutic options.

Collaborations

Throughout his career, Stephen has collaborated with notable colleagues, including Pingyun Chen and Ricky Wayne Couch. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Stephen A R Carino's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing health challenges. His work continues to pave the way for advancements in treatment options for patients suffering from allergic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…